Randomized clinical trial of self versus clinical administration of subcutaneous depot medroxyprogesterone acetate

Contraception

Volumn 89, Issue 5, 2014, Pages 352-356

  Beasley, Anitra ^a   White, Katharine O'Connell ^b   Cremers, Serge ^c   Westhoff, Carolyn ^c  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b BAYSTATE MEDICAL CENTER   (United States)

^c Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

Contraception; Depot medroxyprogesterone acetate; Injectable; Self administration

Indexed keywords

MEDROXYPROGESTERONE ACETATE; CONTRACEPTIVE AGENT;

ADULT; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG SELF ADMINISTRATION; FAMILY PLANNING; FEASIBILITY STUDY; FEMALE; HUMAN; INTERMETHOD COMPARISON; RANDOMIZED CONTROLLED TRIAL; SELF REPORT; COMPARATIVE STUDY; SUBCUTANEOUS DRUG ADMINISTRATION; YOUNG ADULT;

ADULT; CONTRACEPTIVE AGENTS, FEMALE; FEASIBILITY STUDIES; FEMALE; HUMANS; INJECTIONS, SUBCUTANEOUS; MEDROXYPROGESTERONE ACETATE; SELF ADMINISTRATION; YOUNG ADULT;

EID: 84900299942     PISSN: 00107824     EISSN: 18790518     Source Type: Journal    
DOI: 10.1016/j.contraception.2014.01.026     Document Type: Article

References (19)

1. J.J. Frost, J.E. Darroch, and L. Remez Improving contraceptive use in the United States Brief 2008 Guttmacher Institute New York
2. C. Moreau, K. Cleland, and J. Trussell Contraceptive discontinuation attributed to method dissatisfaction in the United States Contraception 76 4 2007 267 272
3. C. Paul, D.C.G. Skegg, and S. Williams Depot medroxyprogesterone acetate: Patterns of use and reasons for discontinuation Contraception 56 4 1997 209 214
4. M. Polaneczky, and M. Liblanc Long-term depot medroxyprogesterone acetate (Depo-Provera) use in inner-city adolescents J Adolesc Health 23 2 1998 81 88
5. L. Bahamondes, N.M. Marchi, H.M. Nakagava, M.L. De Melo, L. Cristofoletti Mde, and E. Pellini et al. Self-administration with UniJect of the once-a-month injectable contraceptive Cyclofem Contraception 56 5 1997 301 304
6. S. Prabhakaran, and A. Sweet Self-administration of subcutaneous depot medroxyprogesterone acetate for contraception: feasibility and acceptability Contraception 85 5 2012 453 457
7. S.T. Cameron, A. Glasier, and A. Johnstone Pilot study of home self-administration of subcutaneous depo-medroxyprogesterone acetate for contraception Contraception 85 5 2012 458 464
8. R.L. Williams, D.J. Hensel, and J.D. Fortenberry Self-administration of subcutaneous depot medroxyprogesterone acetate by adolescent women Contraception 88 3 2013 401 407
9. World Health Organization Medical eligibility criteria for contraceptive use 2004 WHO Press Geneva Available from: http://www.who.int/reproductive- health/publications/mec/mec.pdf
10. V.I. Rickert, L. Tiezzi, J. Lipshutz, J. Leon, R.D. Vaughan, and C. Westhoff Depo now: preventing unintended pregnancies among adolescents and young adults J Adolesc Health 40 1 2007 22 28
11. Pfizer depo-subQ provera 104(r) medroxyprogesterone acetate injectable suspension 104 mg/0.65 mL: physician information 2009 Pharmacia and Upjohn Company New York Available from: http://labeling.pfizer.com/ShowLabeling.aspx? id=549
12. C.M. Estes, J. Ramierez, L. Tiezzi, and C. Westhoff Self pregnancy testing in an urban family planning clinic: promising results for a new approach to contraceptive follow-up Contraception 77 1 2008 40 43
13. A. Ortiz, M. Hiroi, F.Z. Stanczyk, U. Goebelsmann, and D.R. Mishell Serum medroxyprogesterone acetate (MPA) concentrations and ovarian function following intramuscular injection of Depo-MPA J Clin Endocrinol Metab 44 1 1977 32 39
14. D.R. Mishell Pharmacokinetics of depot medroxyprogesterone acetate contraception J Reprod Med 41 5 suppl 1996 381 390
15. C. Picardo, and S. Ferreri Pharmacist-administered subcutaneous depot medroxyprogesterone acetate: a pilot randomized controlled trial Contraception 82 2 2010 160 167
16. F. Lakha, C. Henderson, and A. Glasier The acceptability of self-administration of subcutaneous Depo-Provera Contraception 72 1 2005 14 18
17. N.L. Stanwood, K. Eastwood, and A. Carletta Self-injection of monthly combined hormonal contraceptive Contraception 73 1 2006 53 55
18. S. Koetsawang, K. Shrimanker, and K. Fotherby Blood levels of medroxyprogesterone acetate after multiple injections of DepoProvera or CycloProvera Contraception 20 1 1979 1 4
19. B. Keith Home-based administration of depo-subQ provera 104(tm) in the Uniject(tm) Injection System: A literature Review 2011 Seattle PATH